Munafa Stock Market Course + Intraday & FNO calls 
Intellia Therapeutics (NTLA) Technical (Analysis) Reports Intellia Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Intellia Therapeutics (NTLA)
Technical Analysis Report for NASDAQ stock NTLA Intellia Therapeutics. Dated: 06 Feb 2026 Updated Daily. Stock trades under Health Care Deals in Biotechnology In Vitro In Vivo Diagnostic Substances in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock NTLA Intellia Therapeutics then click here. or read Experts views on Intellia Therapeutics or Forecast & share price targets of Intellia Therapeutics
Intellia Therapeutics Opened at 11.17 and Closed at: 12.27, which is 9.62% of previous session's close. It moved within a range of 10.84 and 12.33
The session was a Bullish session with an average volume of 3370919, which is -73.46% of previous session's volumes.
- The stock has shown an up move, and its short term trend is also positive and in an uptrend.
- The stock has shown an up move, and its mid term trend is also positive and in an uptrend.
- The stock has shown an up move, and its long term trend is also positive and in an uptrend.
A Golden cross was found 8 days back on long term averages
Support for tomorrow is 11.56 and resistance for tomorrow is 13.05
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 11.3, 10.32 resistance for tomorrow's hourly charts is 12.79, 13.3
10 Day SMA for Intellia Therapeutics (NTLA) is 13.14 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Intellia Therapeutics (NTLA) is 12.94 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Intellia Therapeutics (NTLA) is 10.72 and the stock is trading above these levels. This is a good sign for its mid to long term trend
100 Day SMA is 13.65 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Intellia Therapeutics is 11.89 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Intellia Therapeutics is at 12.94 and 200 DMA is at 11.89, while 50 DMA and 100 DMA are at 10.72 and 13.65 respectively
Intellia Therapeutics (NTLA) moving average of 20 SMA is at 12.94 and 20 EMA is at 12.51
| Date | Closing Price | 20 SMA | 20 EMA |
| 06 Fri Feb | 12.27 | 12.94 | 12.51 |
| 05 Thu Feb | 11.09 | 12.85 | 12.53 |
| 04 Wed Feb | 12.36 | 12.8 | 12.68 |
| 03 Tue Feb | 13.06 | 12.67 | 12.71 |
| 02 Mon Feb | 13.02 | 12.49 | 12.67 |
| 30 Fri Jan | 13.15 | 12.3 | 12.63 |
Intellia Therapeutics (NTLA) moving average of 50 SMA is at 10.72 and 50 EMA is at 11.96
| Date | Closing Price | 50 SMA | 50 EMA |
| 06 Fri Feb | 12.27 | 10.72 | 11.96 |
| 05 Thu Feb | 11.09 | 10.64 | 11.95 |
| 04 Wed Feb | 12.36 | 10.58 | 11.98 |
| 03 Tue Feb | 13.06 | 10.5 | 11.96 |
| 02 Mon Feb | 13.02 | 10.4 | 11.91 |
| 30 Fri Jan | 13.15 | 10.31 | 11.86 |
Intellia Therapeutics (NTLA) moving average of 100 SMA is at 13.65 and 100 EMA is at 12.17
| Date | Closing Price | 100 SMA | 100 EMA |
| 06 Fri Feb | 12.27 | 13.65 | 12.17 |
| 05 Thu Feb | 11.09 | 13.64 | 12.17 |
| 04 Wed Feb | 12.36 | 13.64 | 12.19 |
| 03 Tue Feb | 13.06 | 13.63 | 12.19 |
| 02 Mon Feb | 13.02 | 13.62 | 12.17 |
| 30 Fri Jan | 13.15 | 13.6 | 12.15 |
Intellia Therapeutics (NTLA) moving average of 200 SMA is at 11.89 and 200 EMA is at 12.66
| Date | Closing Price | 200 SMA | 200 EMA |
| 06 Fri Feb | 12.27 | 11.89 | 12.66 |
| 05 Thu Feb | 11.09 | 11.86 | 12.66 |
| 04 Wed Feb | 12.36 | 11.84 | 12.68 |
| 03 Tue Feb | 13.06 | 11.82 | 12.68 |
| 02 Mon Feb | 13.02 | 11.79 | 12.68 |
| 30 Fri Jan | 13.15 | 11.75 | 12.68 |
Xtl Biopharmaceuticals has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Xtl Biopharmaceuticals, about 41.49% more returns!
Intellia Therapeutics has performed better than Vistagen Therapeutics in short term. Holding Intellia Therapeutics could be a better choice for now!
Twist Bioscience has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Twist Bioscience, about 21.2% more returns!
Intellia Therapeutics has performed better than Sellas Life in short term. Holding Intellia Therapeutics could be a better choice for now!
Solid Biosciences has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Solid Biosciences, about 5.04% more returns!
Intellia Therapeutics has performed better than Phio Pharmaceuticals in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics has performed better than Mannkind Corporation in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics has performed better than Lakeland Industries in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics has performed better than Karyopharm Therapeutics in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics has performed better than Acadia Pharmaceuticals in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics has performed better than Accuray Incorporated in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics has performed better than Arsanis Inc in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics has performed better than Benitec Biopharma in short term. Holding Intellia Therapeutics could be a better choice for now!
Coherus Biosciences has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Coherus Biosciences, about 7.67% more returns!
Denali Therapeutics has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Denali Therapeutics, about 5.28% more returns!
Intellia Therapeutics has performed better than Electrocore Inc in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics has performed better than National Vision in short term. Holding Intellia Therapeutics could be a better choice for now!
Intellia Therapeutics has performed better than Hutchison China in short term. Holding Intellia Therapeutics could be a better choice for now!
Iridex Corporation has performed better than Intellia Therapeutics in short term. You could have earned much better returns by investing in Iridex Corporation, about 8.75% more returns!
Intellia Therapeutics Technical analysis of indicators
Price action analysis of Intellia Therapeutics (NTLA) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Intellia Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Intellia Therapeutics in short term but the sell signal is initial and weak.
Intellia Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be moving up
CCI has generated a buy signal for Intellia Therapeutics in short term but BUY signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Intellia Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 13.44 and Intellia Therapeutics NTLA stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Intellia Therapeutics NTLA stock. Volume based technical analysis of Intellia Therapeutics NTLA stock is negative.
Intellia Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock NTLA Intellia Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And NTLA Experts View which covers a lot of information including buying and selling signals
NTLA future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Intellia Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Intellia Therapeutics (NTLA) Technical (Analysis) Reports Intellia Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Video Correct Way Of Technical Analysis How To Find Entry Exit Points On Charts
Hindi Video Most Important Stock Market Video. No Success Without This Formula
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance
